How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like Peregrine Reports Financial Results For The Third Quarter Of Fiscal Year 2017 And Recent Developments March 13, 2017 Spark's Good Week Continues With Signing of Huge Lease Near HQ December 7, 2017 <b>Sonar Products</b>, Stratus Pharma Ordered to Cease Operations June 15, 2017
Peregrine Reports Financial Results For The Third Quarter Of Fiscal Year 2017 And Recent Developments March 13, 2017
